Article Overview

This article addresses a hospital setting billing question about whether radiopharmaceutical reporting should continue when myocardial perfusion imaging services are bundled in payment. It explains the broader reimbursement context for hospital outpatient claims, including how charge data supports Medicare rate-setting under HOPPS. The piece is relevant to hospital coders, billing staff, and reimbursement professionals who work with nuclear cardiology and outpatient payment policy.